IMUX (Immunic) Shiller PE Ratio: (As of Aug. 27, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

IMUX Immunic Inc IMUX
32 GF Score
Price $16.49
! 3 Warning Signs
View Full Analysis

What is Immunic Shiller PE Ratio?

Shiller PE for Stocks: The True Measure of Stock Valuation


Immunic  (NAS:IMUX) Shiller PE Ratio Explanation

Compared with the regular PE Ratio, which works poorly for cyclical businesses, the Shiller PE Ratio smoothed out the fluctuations of profit margins during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Shiller PE Ratio should give similar results to regular PE Ratio.

Compared with the PS Ratio, the Shiller PE Ratio makes the comparison between different industries more meaningful.


Be Aware

Shiller PE Ratio assumes that over the long term, businesses and profitability revert to their means. If a company's business model does not work in the future compared with the past, Shiller PE Ratio and PS Ratio will give false valuations.


Immunic Shiller PE Ratio Related Terms


Immunic Shiller PE Ratio Historical Data

* Premium members only.

The historical data trend for Immunic's Shiller PE Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Immunic Shiller PE Ratio Chart

Immunic Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shiller PE Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Immunic Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Shiller PE Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

IMUX vs MDWD, WHWK, IVVD: Shiller PE Ratio Comparison

For the Biotechnology subindustry, Immunic's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Immunic Shiller PE Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Immunic's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Immunic's Shiller PE Ratio falls into.


IMUX
32GF Score
Immunic Inc IMUX
Shiller PE Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Immunic Shiller PE Ratio Calculation

For Shiller PE Ratio, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller PE Ratio is also called PE10.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Immunic's E10 for the quarter that ended in Jun. 2026 is calculated as:

For example, Immunic's adjusted earnings per share data for the three months ended in Jun. 2026 was:

Adj_EPS=Earnings per Share (Diluted)/CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=-0.8/333.9520*333.9520
=-0.800

Current CPI (Jun. 2026) = 333.9520.

Immunic Quarterly Data

Earnings per Share (Diluted) CPI Adj_EPS
201609 -128.000 241.428 -177.054
201612 -148.000 241.432 -204.716
201703 -156.000 243.801 -213.685
201706 -116.000 244.955 -158.145
201709 -120.000 246.819 -162.363
201712 -140.000 246.524 -189.650
201803 -136.000 249.554 -181.995
201806 -120.000 251.989 -159.032
201809 -112.000 252.439 -148.165
201812 -24.000 251.233 -31.902
201903 -50.900 254.202 -66.869
201906 -15.200 256.143 -19.817
201909 -8.200 256.759 -10.665
201912 -5.600 256.974 -7.278
202003 -7.900 258.115 -10.221
202006 -9.000 257.797 -11.659
202009 -7.000 260.280 -8.981
202012 -4.600 260.474 -5.898
202103 -16.300 264.877 -20.551
202106 -8.200 271.696 -10.079
202109 -7.600 274.310 -9.252
202112 -6.000 278.802 -7.187
202203 -7.400 287.504 -8.596
202206 -7.200 296.311 -8.115
202209 -6.900 296.808 -7.763
202212 -16.200 296.797 -18.228
202303 -5.800 301.836 -6.417
202306 -5.400 305.109 -5.910
202309 -5.100 307.789 -5.534
202312 -4.800 306.746 -5.226
202403 -3.000 312.332 -3.208
202406 -2.100 314.175 -2.232
202409 -2.400 315.301 -2.542
202412 -2.500 315.605 -2.645
202503 -2.510 319.799 -2.621
202506 -2.030 322.561 -2.102
202509 -1.300 324.800 -1.337
202512 -0.700 324.054 -0.721
202603 -1.080 330.213 -1.092
202606 -0.800 333.952 -0.800

Add all the adjusted EPS together and divide 10 will get our E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Immunic Business Description

Other Exchanges 10V:Germany
Address 1200 Avenue of the Americas, Suite 200, New York, NY, USA, 10036
Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function. It operates in one segment which is Life science segment.
32GF Score

Get the complete analysis for IMUX

Shiller PE Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$16.49
Price